Search research articles
Contact Us
Filters
Showing results (21-30 of 74) with videos related to
Page
of 8
Sort By:
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
December 25, 2007
Malignant clear cell hidradenoma of the vulva: report of a unique case and review of the literature
Olaf J Biedrzycki, Barnaby Rufford, Mark Wilcox, et al.
Drug Safety
|
December 31, 2015
Safety of Dalbavancin in the Treatment of Skin and Skin Structure Infections: A Pooled Analysis of Randomized, Comparative Studies
Michael W Dunne, George H Talbot, Helen W Boucher, et al.
Journal of Clinical Microbiology
|
June 15, 2018
Sensitivity of Single-Molecule Array Assays for Detection of Clostridium difficile Toxins in Comparison to Conventional Laboratory Testing Algorithms
Alice Banz, Aude Lantz, Brigitte Riou, et al.
Diseases of the Colon and Rectum
|
July 21, 2009
An assessment of bacterial dysbiosis in pouchitis using terminal restriction fragment length polymorphisms of 16S ribosomal DNA from pouch effluent microbiota
Michael Lim, John D W Adams, Mark Wilcox, et al.
Journal of Global Antimicrobial Resistance
|
December 18, 2021
Treatment outcomes of secondary bacteraemia in patients treated with ceftaroline fosamil: pooled results from six phase III clinical trials
Matthew Dryden, Michal Kantecki, Jean Li Yan, et al.
Infectious Diseases and Therapy
|
November 6, 2021
Impact of Underlying Comorbidities on Outcomes of Patients Treated with Ceftaroline Fosamil for Complicated Skin and Soft Tissue Infections: Pooled Results from Three Phase III Randomized Clinical Trials
Mark Wilcox, Jean Li Yan, Pedro L Gonzalez, et al.
The Journal of Antimicrobial Chemotherapy
|
June 23, 2023
In vivo emergence of a still uncommon resistance to fidaxomicin in the urgent antimicrobial resistance threat Clostridioides difficile
Hélène Marchandin, Cyril Anjou, Gaëtan Poulen, et al.
The New England Journal of Medicine
|
June 5, 2014
Once-weekly dalbavancin versus daily conventional therapy for skin infection
Helen W Boucher, Mark Wilcox, George H Talbot, et al.
Journal of Clinical Medicine
|
November 25, 2020
An Outbreak of <i>Clostridium</i> (<i>Clostridioides</i>) <i>difficile</i> Infections within an Acute and Long-Term Care Wards Due to Moxifloxacin-Resistant PCR Ribotype 176 Genotyped as PCR Ribotype 027 by a Commercial Assay
Elena Novakova, Nina Kotlebova, Anezka Gryndlerova, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
April 15, 2022
<i>Clostridioides difficile</i> positivity rate and PCR ribotype distribution on retail potatoes in 12 European countries, January to June 2018
Valerija Tkalec, Virginie Viprey, Georgina Davis, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 74) with videos related to
Sort By:
Page
of 8
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
December 25, 2007
Malignant clear cell hidradenoma of the vulva: report of a unique case and review of the literature
Olaf J Biedrzycki, Barnaby Rufford, Mark Wilcox, et al.
Drug Safety
|
December 31, 2015
Safety of Dalbavancin in the Treatment of Skin and Skin Structure Infections: A Pooled Analysis of Randomized, Comparative Studies
Michael W Dunne, George H Talbot, Helen W Boucher, et al.
Journal of Clinical Microbiology
|
June 15, 2018
Sensitivity of Single-Molecule Array Assays for Detection of Clostridium difficile Toxins in Comparison to Conventional Laboratory Testing Algorithms
Alice Banz, Aude Lantz, Brigitte Riou, et al.
Diseases of the Colon and Rectum
|
July 21, 2009
An assessment of bacterial dysbiosis in pouchitis using terminal restriction fragment length polymorphisms of 16S ribosomal DNA from pouch effluent microbiota
Michael Lim, John D W Adams, Mark Wilcox, et al.
Journal of Global Antimicrobial Resistance
|
December 18, 2021
Treatment outcomes of secondary bacteraemia in patients treated with ceftaroline fosamil: pooled results from six phase III clinical trials
Matthew Dryden, Michal Kantecki, Jean Li Yan, et al.
Infectious Diseases and Therapy
|
November 6, 2021
Impact of Underlying Comorbidities on Outcomes of Patients Treated with Ceftaroline Fosamil for Complicated Skin and Soft Tissue Infections: Pooled Results from Three Phase III Randomized Clinical Trials
Mark Wilcox, Jean Li Yan, Pedro L Gonzalez, et al.
The Journal of Antimicrobial Chemotherapy
|
June 23, 2023
In vivo emergence of a still uncommon resistance to fidaxomicin in the urgent antimicrobial resistance threat Clostridioides difficile
Hélène Marchandin, Cyril Anjou, Gaëtan Poulen, et al.
The New England Journal of Medicine
|
June 5, 2014
Once-weekly dalbavancin versus daily conventional therapy for skin infection
Helen W Boucher, Mark Wilcox, George H Talbot, et al.
Journal of Clinical Medicine
|
November 25, 2020
An Outbreak of <i>Clostridium</i> (<i>Clostridioides</i>) <i>difficile</i> Infections within an Acute and Long-Term Care Wards Due to Moxifloxacin-Resistant PCR Ribotype 176 Genotyped as PCR Ribotype 027 by a Commercial Assay
Elena Novakova, Nina Kotlebova, Anezka Gryndlerova, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
April 15, 2022
<i>Clostridioides difficile</i> positivity rate and PCR ribotype distribution on retail potatoes in 12 European countries, January to June 2018
Valerija Tkalec, Virginie Viprey, Georgina Davis, et al.
Page
of 8